By Pension and Benefits Editorial Staff
In Notice 2019-45, the IRS has expanded the list of preventive care benefits that may be provided by a high deductible health plan (HDHP) to include certain care for chronic conditions. The Treasury Department and the IRS, in consultation with the Department of Health and Human Services, have determined that certain medical care services received and items purchased, including prescription drugs, for certain chronic conditions should be classified as preventive care for someone with that chronic condition.
The IRS noted that individuals covered by an HDHP generally may establish and deduct contributions to a health savings account (HSA) as long as they have no disqualifying health coverage. To qualify as a HDHP, the plan generally may not provide benefits for any year until the minimum deductible for that year is satisfied. However, an HDHP is not required to have a deductible for preventive care (as defined for purposes of the HDHP/HSA rules).
Notice 2019-45 clarified that any medical care previously recognized as preventive care for these rules is still treated as preventive care. Some examples of the additional preventive care services and items for chronic conditions that may be treated as preventive care are, as follows:
- ACE inhibitors for congestive heart failure, diabetes, and/or coronary artery disease;
- Beta-blockers for congestive heart failure and/or coronary artery disease;
- Insulin and other glucose lowering agents for diabetes;
- Selective serotonin reuptake inhibitors for depression; and
- Statins for heart disease and/or diabetes.
To see the full list of additional preventive services, see Notice 2019-45. The notice is effective as of July 17, 2019.
SOURCE: IRS Notice 2019-45, I.R.B. 2019-32, August 5, 2019.
Interested in submitting an article?
Submit your information to us today!Learn More